Bilaketaren emaitzak - A. B. SUMAROKOV

NEW ANTIPLATELET DRUGS. PART 2 nork A. B. Sumarokov

Connect to this object online.

NEW ANTIPLATELET DRUGS (PART 1) nork A. B. Sumarokov

Connect to this object online.

NEW ANTIPLATELET DRUGS (PART 1) nork A. B. Sumarokov

Connect to this object online.

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding nork A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin

Connect to this object online.

ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS nork L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo

Connect to this object online.

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients nork A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin

Connect to this object online.

INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY? nork N. V. LOMAKIN, A. B. SUMAROKOV, Yu. V. DOTSENKO, I. A. UCHITEL, L. I. BURYACHKOVSKAYA

Connect to this object online.